HCV, Hepatitis C virus; 3'NTR, 3' nontranslated region of HCV RNA genome; 5'NTR, 5'nontranslated region of HCV RNA genome; PNA, peptide nucleic acid; siRNA, small interfering RNA; NS5A, nonstructural protein 5A of hepatitis C virus; NS5B, non-structural protein 5B of hepatitis C virus; FUSE, far upstream element; HCC, hepatocellular carcinoma; IRES, internal ribosomal entry site; DMEM, Dulbecco's modified eagle medium.
INTRODUCTION
The hepatitis C virus, a blood-borne pathogen that causes chronic hepatitis, is the primary reason for liver transplantation in the United States. HCV preferentially replicates in liver tissue without any direct cytopathic effect and thus is able to maintain long-term, persistent infection.
More than 50% of HCV-infected patients do not respond to treatment; instead, the majority of patients develop chronic hepatitis C, which leads to progressive liver fibrosis, cirrhosis, endstage liver disease, and hepatocellular carcinoma (HCC).
The hepatitis C virus is a positive single-stranded RNA virus of 9.6-kb genome. After its entry into cells, the (+) strand RNA first serves as a messenger RNA for the translation of viral proteins. Newly synthesized HCV replicase (NS5B) then copies the (+) stand RNA genome into (-) strand RNA, which serves as a template for the production of viral genome. The conserved 5' and 3' nontranslated (5'NTR and 3'NTR) regions of the HCV genome have multiple regulatory elements that are essential for replication of HCV and translation of viral proteins. While the 5'NTR of HCV contains the internal ribosomal entry site (IRES), which is required for capindependent translation of (+)-strand HCV RNA [1] [2] [3] [4] , it is also the 3' region of the minus-strand RNA, which functions as the initiation site for replication of the (+) strand HCV RNA genome.
The 3' regions of both (-) and (+) strands HCV RNA are highly structured and serve as the initiation sites for viral replication 5 . Various cellular proteins have been shown to interact with 5'NTR of HCV RNA; these include La autoantigen 6 nuclear factors NF90, NF 110, NF45, and RNA helicase A 7 , as well as the polypyrimidine tract binding protein [8] [9] [10] . Recently, we affinitycaptured different cellular proteins interacting with HCV 3'NTR and identified them by LC/MS/MS; some of these proteins were found to be essential for HCV replication as confirmed by siRNA 11 .
Another recent study using sequence-specific gene silencing of Ran screen has identified 26 human genes encoding proteins that physically interact with HCV RNA or protein and modulate HCV replication 12 . A more direct approach would be to capture the replicating HCV RNA genome in situ under physiological conditions, then identify all the cellular and viral factors associated with the viral genome. The structured HCV genome and the interplay of tightly regulated viral and host factors assembled on it should be highly specific within the cells. We present a novel strategy to affinity-capture the replicating HCV RNA and associated cellular and viral proteins in MH14 cells carrying actively replicating HCV replicons. We have identified these proteins by proteomics technology.
EXPERIMENTAL PROCEDURE
MH14 cells: Cured MH14 and MH14 cells (a kind gifts from Makoto Hijikata, Japan) carrying replicative HCV subgenomic replicons were grown in DMEM medium (Cellgrow) supplemented with 10% fetal calf serum, 100µg/ml each of penicillin/streptomycin and 300 µg /ml of G418 13, 14 .
Cured MH14 cells were prepared by treating MH14 cells with 5,000 IU/ml of alpha interferon for 2 weeks. The absence of replicon RNA and viral proteins was checked by Northern blotting, RT-PCR, and Western blotting 14 . Cells were grown at 37°C with 5% CO 2 .
Peptide nucleic acid (PNA).
We conjugated a 15-mer PNA targeted to the HCV genome with neamine at the N-terminus as described before 15 The PNA-neamine conjugate contained biotin at the C-terminus via Lys residue ( Fig. 1) . We obtained the PNA sequence (neamine-TACTCG TGCTTAGGA-Lys-biotin) which is complementary to the N-terminal HCV core coding region downstream of the 5' NTR in the MH14 HCV subgenomic replicon (Fig. 1C ) on solid support from Panagene (South Korea) and conjugated it with neamine monomer essentially as described before 15 .
Preparation of 32
P-labeled RNA fragment corresponding to 5'NTR. The HCV 5'-NTR flanking with 3' N-terminal HCV core coding region was amplified by PCR from the pMH14 template using up-primer containing T-7 promoter (CGG GAG AGC CAT AGT GG) and downprimer complementary to the HCV core coding region (GGT TTT TCT TTG AGG TTT AGG).
The PCR product corresponding to domains III and IV of 5'NTR and the 36 nucleotide of the Nterminal coding sequence of HCV core were transcribed to generate 244-base runoff transcripts, using the T7 transcription kit from Roche Applied Sciences. The RNA transcript was internally labeled by including [α-
32
P] UTP (3,000 Ci/mmol; Amersham Life Sciences) in the reaction solution. Reactions were carried out according to the manufacturer's protocols. The transcripts were purified by phenol-chloroform extraction and ethanol precipitation, dissolved in DEPC-treated water, and stored at -80°C. Following treatment with RNase-free DNase I to remove template DNA, the RNA was precipitated with lithium chloride, resuspended in RNasefree water and used to determine the binding specificity of Nea-PNA-biotin conjugate.
Gel retardation assay:
The affinity and specificity of the anti-HCV Nea-PNA-biotin conjugate for its target sequence was evaluated by gel electrophoretic mobility shift analysis. The protease inhibitor cocktail (mini-EDTA-free, Roche Applied Science) 1mM DTT, 100mM NaCl, 20mM HEPES (pH 7.5), and 20 U/ml SUPERaseIN. The mixture was incubated on ice for 60 min, after which 75 µl of streptavidin-coated paramagnetic bead suspension (Dynal; Invitrogen) was added to the mixture to capture the biotinylated PNA probe. 4 Cl, 7 mM KCl, and 4.5 mM magnesium acetate. We layered the washed cells with lysolecithin (200 µg/ml) in the wash buffer for 5 min, then aspirated all the solution from the plates as described earlier 16, 17 . We then layered the cells with reticulocyte buffer containing 1.6 mM Tris-acetate (pH 7.8), 80 mM KCl, 2 mM Mg acetate, 0.25 mM ATP, 0.1 mM dithiothreitol, and 10 U of RNasin containing 0.5 µM of anti-HCV PNA-neamine-biotin conjugate designed to capture (+) strand HCV RNA-protein complex. After incubation at room temperature for 2 h, the cells were washed once with the same buffer, gently scraped from each plate, and lysed on ice.
We centrifuged the lysed cells for 10 min at low speed (7,000 xg). The supernatant (S7 fraction) was incubated on ice with 150 µl of paramagnetic streptavidin beads for 1 h to capture the HCV RNA-protein complex bound to nea-PNA-biotin conjugate. We washed the beads 6 times with the reticulocyte buffer containing 500 mM NaCl. We conjugated 15-mer biotinylated
PNAs with neamine at the N-terminus and with biotin at the C-terminus via a Lys residue ( Table 1 ). We also determined the localization of the conjugate in the cells. As shown in figure 4C , the conjugate is uniformly distributed in the cytosol and also localized in the nucleus upon prolonged incubation. The PNA-Nea-HCV-Core conjugate efficiently penetrated the cells and captured the HCV-RNA protein complex in-situ from MH 14 cells (Fig. 5) . Proteins bands associated with the captured HCV (+) RNA genome from MH14 cells could be seen in the gel (Fig. 5, lane 3) . Binding of the RNA-protein complex to the PNA probe was tight enough to withstand washing with 0.5M salt, as only few protein bands could be seen in the washes (Fig. 5A, lanes 4 and 5) . In contrast, the affinity capture lane from cured-MH14 cells devoid of HCV replicons showed few protein bands in the gel (Fig. 5B, lane 3) . LC/MS/MS analysis of these proteins indentified 23 cellular factors associated with biotinylated PNA-streptavidin complex (supplemental Table 1 ). Among these, 
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Identification of cellular or viral proteins associated with HCV (+) strand RNA genome:
For identification of specific cellular and viral proteins associated with the HCV RNA genome, the RNA-protein complex released in Laemmli gel loading buffer was processed for LC/MS/MS analysis to achieve the highest level of confidence in our identification. We used LC/MS/MS tandem mass spectrometric detection. The LC/MS/MS approach has three distinct advantages:
It separates the tryptic peptides before mass spectrometric analysis, provides sequence information for fragmented peptides, and identifies proteins in protein mixtures. These proteins are listed in Table 1 with their accession numbers obtained from the protein database (NCBI).
We identified three HCV proteins (NS3-4a protease-helicase, NS5A and NS5B) and 83 cellular analysis also demonstrated that four major disease and disorder developments were significantly associated with our affinity-captured proteins. The majority of them are related to cancer (46%), Infectious disease (30%), reproductive system disease (15%), and hepatic system disease (7%) (Fig. 6A) . or translation 28 while others (Stau1, ADR1 and HSP60) were considered as the novel targets.
Silencing
The siRNA was delivered into MH14 cells, which carry actively replicating HCV replicons. Figure   6 shows that expression of all the siRNA targeted genes was reduced by more than 95% as . We found that down regulation of IGF2BP1 had no effect on HCV replication, but it caused approximately 60% reduction in the expression of viral protein NS5A suggesting its specific role in regulation of translation of HCV proteins.
DISCUSSION
Earlier, we used in-vitro transcribed HCV 3'NTR annealed with biotinylated oligo-DNA as bait to capture interacting cellular proteins from cell lysate 11 . Although this strategy identified many cellular proteins interacting with HCV 3'NTR, some proteins interacted with the oligo-DNA probe alone; they were also identified and subtracted from the list as nonspecific binders.
In this study, we devised a novel strategy to capture the replicating HCV (+) strand RNA genome in situ and identified associated cellular or viral factors. This strategy, which uses a sequence-specific biotinylated peptide nucleic acid (PNA) conjugated with polycationic neamine moiety of neomycin, has four advantages: PNA, being an unnatural DNA mimic with no sugar phosphate backbone, is not recognized by cellular proteins and does not have any affinity for them, so that background signal due to nonspecific protein binding eliminated; binding of PNA to its target is stoichiometric and irreversible under physiological conditions; the PNA-neamine conjugate in either free form or bound to its target sequence is highly stable and completely resistant to cellular nucleases and proteases; and, most significantly, PNA-neamine conjugate efficiently penetrates the cells and binds to its target RNA in the cytosol, which can then be quantitatively recovered from the cell lysate. We used this strategy specifically to capture the RNA and DNA helicases are another important group of proteins found to be associated with HVC (+) strand RNA. Among these, DDX3 has been implicated in several processes that regulate gene expression. This protein has been the prime target for many viruses, including HCV, HBV, and HIV, which interact with DDX3 and modulate its function 43 . HCV core protein specifically interacts with DDX3 and may be involved in regulating host cell mRNA translation 44 . DDX6 (Rck/p54) is a cellular RNA helicase with ATP-dependent RNA-unwinding activity 45 that has been suggested to function as a proto-oncogene. It is overexpressed in human hepatocytes from patients with chronic hepatitis C 33 and in some and colorectal cancers 46 , also, its helicase activity is essential for efficient HCV replication
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. The RNA helicase DDX5 (growth-related nuclear 68 protein), which interacts with the C terminal region of HCV NS5B, has been suggested to be part of the HCV replicase complex 47 , whereas Ras-GTPase-activating proteinbinding protein 1 (G3BP1) interacts with both HCV NS5B and the 5' end of the HCV minusstrand RNA, suggesting that it is part of HCV replication complex 48 . Another RNA helicase DDX30 that we scored has been shown to have an inhibitory effect on HIV-1 packaging and to reduce viral infectivity . A similar role of Staufen in HCV replication may be suggested since we found that its down-regulation in MH14 cells carrying replicating HCV replicons drastically reduced HCV replication (Fig.6) . It is possible that Staufen may be involved in HCV RNA dimerization to regulate the molecular transition from the synthesis of (+) strand and (-) strand viral RNA to viral RNA translation. The APOBEC1 complementation factor (ACF) that we have identified is an essential component of an editing complex involved in introducing site-specific deamination of cytosine in mammalian apolipoprotein B mRNA. Although the human liver is deficient in APOBEC1 expression, its interacting partner, ACF, is abundantly expressed and suppress apoptosis in liver cells 52, 53 .
However, hepatitis C virus triggers the expression of APOBEC1 in hepatocytes and chronic hepatic inflammation caused by HCV infection 54 .The cytidine deaminase activity expression induced by APOBEC family members may function as a genome mutator that generates somatic mutation in targeted host genes, thus contributing to tumor genesis 55 .
As expected, we also found an array of transcriptional regulators to be associated with the HCV genome. The Fuse binding protein (FBP) is a transcription transactivator of cmyc gene 56, 57 . We have demonstrated that FBP interacts with HCV NS5A and significantly enhances HCV replication while strongly inhibiting translation of viral proteins
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. FBP is not expressed in normal somatic cells, but is overexpressed in HCC and required for tumor growth 58 . Another protein that negatively regulates cellular transcription is the La-related protein LARP7, which was associated with viral RNA. LARP7 binds to 7SK RNA and reverses its antagonistic effect on P-TEFb-mediated stimulation of transcription elongation by RNA polymerase II Another oncogenic protein, KIAA1401, is also a transcriptional system regulator 1 (TSR1) and is required during maturation of the 40S ribosomal subunit in the nucleolus; it also is associated with breast and thymus cancer 70 . ER lipid raft associated 2 isoform 1 (ERLIN2) has been identified as one of the most potently transforming oncogenes expressed in breast cancer 71 .
Autoantigen is a nuclear protein specifically expressed in cancer cells during S and G2 phage. . Another molecular chaperone, calnexin, which has a major role in controlling the quality of folding of HCV glycoproteins 77 was also affinity-captured with HCV RNA.
We have also found several translation factors, ribosomal proteins, and metabolic enzymes associated with HCV genomic RNA. Indeed, the information we have generated regarding the identity of cellular factors associated with replicating HCV (+) RNA subgenomic replicons will provide a strong basis for numerous hypothesis-driven studies on the interactions of cellular factors with viral RNA and proteins, as well as the functions of these factors in establishing chronic HCV infection and promoting its progression to LC and HCC. The major challenges are to determine the hierarchical importance of these interactions between HCV and host cell factors, to delineate how these interactions affect patients infected with HCV and, to determine which of these interactions may be potential targets for therapeutic intervention.
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